Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority of GSK Biologicals' Meningococcal Vaccine (GSK134612) Compared to Licensed MenC-CRM197 Conjugate Vaccine in Healthy Children

NCT00674583 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00674583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00674583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority of GSK Biologicals' Meningococcal Vaccine (GSK134612) Compared to Licensed MenC-CRM197 Conjugate Vaccine in Healthy Children
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
May 9, 2008
Completion date
January 8, 2009
Enrollment
414 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

infections, meningococcal